2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Bms, spanning July 2, 2026 through October 12, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 14 article observations and 14 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
8 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Roche's KRAS G12C inhibitor, divarasib, outperformed rival therapies in a head-to-head Phase 3 trial for lung cancer.